secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001493152-24-047422
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics prices $2.135M offering of stock and warrants at $1.175/unit
--------------------------------------------------------------------------------

- Sold 1,817,017 shares of common stock and warrants to buy 1,817,017 shares at $1.175 per unit.
- Warrants exercisable at $1.05/share, immediately exercisable, 5-year term; gross proceeds ~$2.135M.
- CEO participating, purchasing 42,553 shares and warrants on same terms as other investors.
- Funds to be used for R&D, working capital, and general corporate purposes.
- Closing expected November 25, 2024; Paulson Investment Company acting as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224047422/0001493152-24-047422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315224047422/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer